Patrick Stahl Email & Phone Number

Malvern, PA, US

Raritan, New Jersey, US

• Leading drug product development teams responsible for managing global commercial oncology biotherapeutics and development of next-generation products to clinical & commercial filings
• Managing evaluations of drug delivery technologies for ultrahigh concentration formulations and long-acting injectables central to product enhancement initiatives

Raritan, New Jersey, US

• Managed external CROs and CMOs (USA and Europe) to facilitate formulation development and manufacturing tech transfers for Biotherapeutics portfolio
• Led Biotherapeutics drug product development workflow modules Playbook
• Drove innovation in novel surfactants research and implementation into formulation development workflows

Raritan, New Jersey, US

• Led IgG1, IgG4, and Bispecific New Molecular Entities (NMEs) through formulation screening and candidate selection, manufacturing tech transfers, in-use stability studies, and governance reviews from Pre-NME through.
• Shaped pre-Ph1 drug product development strategy to support a frozen platform that reduces testing and material resources to accelerate program timelines, widens clinical storage capabilities, and extends stability.
• Collaborated with Princeton University researchers to develop next generation high throughput formulation screening approach using Random Sampling-High Dimensional Model Representation
• Interfaced with external CMOs for GLP/GMP manufacturing and provided on-site support at international fill/finish operations
• Generated Process Performance Qualification Master Plan to support Process Validation strategy for Accelerate-to-Value program
• Led Phase 3 formulation development DOE studies on drug substance and pre-filled syringes to support successful BLA filing

Baltimore, MD, US

• Designed growth factor mimetic peptides to functionalize photopatterned hydrogels for microvascular engineering
• Led implementation of collagen mimetic peptide technology in regenerative biomaterials to treat 3rd degree burn wounds using in vivo mouse models

Baltimore, MD, US

• Designed hydrogels with tunable mechanical properties by self-assembly of synthetic collagen mimetic peptides that mimic the structure and folding behavior of triple helical collagen
• Developed synthetic cell scaffolds featuring spatially-controlled presentation of cell-signaling cues employed in tissue engineering applications and to study cell-scaffold interactions
• Encoded growth factor mimetic peptides on collagen scaffolds to induce endothelial cell morphogenesis for microvascular engineering
• Characterized biomimetic peptides to model pathological collagen found in genetically-derived cases of Fuchs’ Endothelial Corneal Dystrophy
• Synthesized fluorescently-labeled peptides to image the extracellular matrix structure of cancerous human tissue sections

College Park, MD, US

Evaluated impact of processing conditions on degree of polymerization of dental resin composites. Created ceramic dental replacement joins by sol-gel processing, optimizing thermal properties to reduce crazing defects during processing.

Silver Spring, MD, US

Characterized the content of ginsenoside active ingredient in commercially available ginseng products using HPLC to analyze product label accuracy.

Doctor Of Philosophy (Phd), Materials Science & Engineering

Bachelor Of Science (B.S.), Materials Science & Engineering